Elizabeth Holmes the founder of Theranos is to be sentenced on September 26th for her convictions of defrauding investors in the blood-testing startup, according to a court filing on Wednesday.
Theranos convinced investors to part with hundreds of millions of dollars on the promise of a device that could diagnose hundreds of medical conditions, including high cholesterol and cancer, just from a few drops of blood.
Theranos later collapsed after the Wall Street Journal published a series of articles, that suggested its devices were flawed and inaccurate.
DirectorsTalk caught up with Marc Howells CEO at Goodbody Health for his thoughts, “Let us use this fraudulent example to show how it is important to select the right health provider, as in this new health conscious world with so much progressive technology we cannot afford to allow this one company to tarnish the great good, that so many providers are bringing to the market. These providers use accredited, quality emerging technologies, which will help people retain their health by providing data key for people to take decisions and actions to improve their lives.”
Goodbody Health Inc. (CSE: GBDY / AQSE: GBDY / FRA: 484 / OTC: SCNNF) are a wellness company, focusing on the Health and Wellness of customers through the local community by the introduction and use of cutting edge diagnostic equipment.